Onconetix, Inc. Increase (Decrease) in Accounts Receivable, Related Parties
Onconetix, Inc. (ONCO) reported Increase (Decrease) in Accounts Receivable, Related Parties of $22.15 thousand for the 9-month period ending 2022-09-30, per its 10-Q filed 2022-11-14.
Discontinued › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInAccountsReceivableRelatedParties · last filed 2022-11-14
- Onconetix, Inc. increase (decrease) in accounts receivable, related parties for the quarter ending 2022-09-30 was $14.31K, a 44.52% increase year-over-year.
- Onconetix, Inc. increase (decrease) in accounts receivable, related parties for the quarter ending 2022-06-30 was -$4.15K, a 156.24% decline year-over-year.
- Onconetix, Inc. increase (decrease) in accounts receivable, related parties for the quarter ending 2022-03-31 was $11.99K, a 137.16% increase year-over-year.
- Onconetix, Inc. increase (decrease) in accounts receivable, related parties for the quarter ending 2021-09-30 was $9.90K.
| Period end | Increase (Decrease) in Accounts Receivable, Related Parties 3 month | Increase (Decrease) in Accounts Receivable, Related Parties 6 month | Increase (Decrease) in Accounts Receivable, Related Parties 9 month |
|---|---|---|---|
| 2022-09-30 | $14.31K derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-14 | $10.16K derived: sum of 2 quarters · filed 2022-11-14 | $22.15K 10-Q · filed 2022-11-14 |
| 2022-06-30 | -$4.15K derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-15 | $7.84K 10-Q · filed 2022-08-15 | |
| 2022-03-31 | $11.99K 10-Q · filed 2022-05-13 | ||
| 2021-09-30 | $9.90K derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-14 | $17.28K derived: sum of 2 quarters · filed 2022-11-14 | $22.34K 10-Q · filed 2022-11-14 |
| 2021-06-30 | $7.38K derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-15 | $12.44K 10-Q · filed 2022-08-15 | |
| 2021-03-31 | $5.06K 10-Q · filed 2022-05-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| HCW Biologics Inc. (HCWB) | United States | $0.004B | -6.15 |
| REVELATION BIOSCIENCES, INC. (REVB) | United States | $0.004B | |
| Aptevo Therapeutics Inc. (APVO) | United States | $0.003B | |
| Sunshine Biopharma Inc. (SBFM) | $0.003B | ||
| 60 DEGREES PHARMACEUTICALS, INC. (SXTP) | United States | $0.004B | -0.59 |
| Alaunos Therapeutics, Inc. (TCRT) | United States | $0.003B | -1.44 |
| Genprex, Inc. (GNPX) | United States | $0.003B | -0.02 |
| Silo Pharma, Inc. (SILO) | United States | $0.003B | -1.57 |
| Lakewood-Amedex Biotherapeutics Inc. (LABT) | United States | $0.004B | |
| Cadrenal Therapeutics, Inc. (CVKD) | United States | $0.004B | -0.90 |